GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » SciBase Holding AB (OSTO:SCIB) » Definitions » Short Interest

SciBase Holding AB (OSTO:SCIB) Short Interest


View and export this data going back to 2015. Start your Free Trial

What is SciBase Holding AB Short Interest?

Short Interest can be expressed as a percentage by dividing the number of shares sold short by the total number of outstanding shares.

Due to the license agreement change with our data vendor, Short Interest related data is no longer available on GuruFocus website.

Competitive Comparison of SciBase Holding AB's Short Interest

For the Medical Devices subindustry, SciBase Holding AB's Short Interest, along with its competitors' market caps and Short Interest data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

SciBase Holding AB's Short Interest Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, SciBase Holding AB's Short Interest distribution charts can be found below:

* The bar in red indicates where SciBase Holding AB's Short Interest falls into.


;
;

SciBase Holding AB Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » SciBase Holding AB (OSTO:SCIB) » Definitions » Short Interest
Comparable Companies
OSTO:NOSA OSTO:DIGN OSTO:ARCOMA NGM:MCLR OSTO:QLINEA OSTO:SPEC XSAT:BIBB XSAT:REDS OSTO:LXB XSAT:PHI ABT BSX SYK MDT XTER:SHL EW SZSE:300760 DXCM XAMS:PHIA ZBH
Traded in Other Exchanges
N/A
Address
Landsvagen 39, Sundbyberg, Stockholm, SWE, 172 63
Website
https://www.scibase.com
SciBase Holding AB is a medical technology company that develops devices for the evaluation of skin disorders such as skin cancer and atopic dermatitis. SciBase's products include Nevisense and Nevisense Go and to date, the platform addresses the areas of melanoma detection, non-melanoma skin cancer detection, and skin barrier assessment. It is the only FDA-approved device for the detection of melanoma and the only MDR-approved technology for skin cancer detection in Europe. The company operates in two segments which includes skin cancer and skin barrier assessment. Majority of the revenue is generated from skin cancer segment. Its geographical segments are Europe/Rest of the World, the United States/North America, and Asia/Oceania.

SciBase Holding AB Headlines

No Headlines